Title | Type | SJR | H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | %Female (2014) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
352 | Ankara Universitesi Eczacilik Fakultesi Dergisi | journal | 13 | 6 | 0 | 346 | 0 | 0 | 0.00 | 57.67 | 50.00 | ||
351 | Japanese Journal of Psychopharmacology | journal | 0.102 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
350 | Journal of Xenobiotics | journal | 11 | 2 | 0 | 53 | 0 | 0 | 0.00 | 26.50 | 44.44 | ||
349 | MedChemComm | journal | 0.942 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
348 | Modern Trends in Pharmacopsychiatry | journal | 0.132 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
347 | Current Psychopharmacology | journal | 0.123 Q4 | 4 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
346 | Metal-Based Drugs | journal | 0.186 Q4 | 40 | 0 | 1 | 0 | 2 | 1 | 0.00 | 0.00 | 0.00 | |
345 | NTP monograph | journal | 0.208 | 2 | 0 | 1 | 0 | 1 | 1 | 1.00 | 0.00 | 0.00 | |
344 | Perspectives in Medicinal Chemistry | journal | 0.108 Q4 | 17 | 5 | 2 | 700 | 0 | 2 | 0.00 | 140.00 | 30.00 | |
343 | Vaccines | journal | 0.123 Q4 | 85 | 42 | 2 | 3639 | 0 | 1 | 0.00 | 86.64 | 45.03 | |
342 | Journal of Experimental Pharmacology | journal | 0.994 Q2 | 23 | 1 | 3 | 23 | 9 | 3 | 3.00 | 23.00 | 33.33 | |
341 | Open Bioactive Compounds Journal | journal | 0.106 Q4 | 6 | 0 | 4 | 0 | 1 | 4 | 0.25 | 0.00 | 0.00 | |
340 | Psychopharmacology and Biological Narcology | journal | 0.106 Q4 | 3 | 0 | 4 | 0 | 1 | 4 | 0.00 | 0.00 | 0.00 | |
339 | Journal of Pharmacy and Pharmacognosy Research | journal | 0.171 Q4 | 17 | 20 | 5 | 784 | 7 | 4 | 1.40 | 39.20 | 59.76 | |
338 | Internet Journal of Pharmacology | journal | 0.104 Q4 | 9 | 0 | 6 | 0 | 0 | 6 | 0.00 | 0.00 | 0.00 | |
337 | Pharmaceutical Reviews | journal | 0.104 Q4 | 6 | 0 | 6 | 0 | 0 | 6 | 0.00 | 0.00 | 0.00 | |
336 | Journal of Immune Based Therapies and Vaccines | journal | 0.760 Q2 | 21 | 0 | 7 | 0 | 19 | 7 | 0.00 | 0.00 | 0.00 | |
335 | Journal of Receptor, Ligand and Channel Research | journal | 0.195 Q3 | 13 | 9 | 9 | 1155 | 6 | 8 | 0.75 | 128.33 | 34.62 | |
334 | Open Neuropsychopharmacology Journal | journal | 0.374 Q3 | 6 | 0 | 10 | 0 | 14 | 10 | 0.00 | 0.00 | 0.00 | |
333 | Open Pharmacology Journal | journal | 0.104 Q4 | 6 | 0 | 10 | 0 | 1 | 9 | 0.11 | 0.00 | 0.00 | |
332 | Neuropsychopharmacology Reports | journal | 22 | 1 | 13 | 0 | 0 | 10 | 0.00 | 0.00 | 0.00 | ||
331 | Cancer Therapy | journal | 0.221 Q3 | 9 | 4 | 14 | 408 | 19 | 14 | 0.18 | 102.00 | 30.00 | |
330 | Reviews of Physiology Biochemistry and Pharmacology | journal | 2.812 Q1 | 70 | 8 | 15 | 1415 | 101 | 15 | 6.73 | 176.88 | 31.03 | |
329 | Drugs in Context | journal | 0.161 Q4 | 36 | 7 | 16 | 361 | 15 | 14 | 0.94 | 51.57 | 31.82 | |
328 | Journal of Applied Therapeutic Research | journal | 0.101 Q4 | 8 | 0 | 17 | 0 | 0 | 17 | 0.00 | 0.00 | 0.00 | |
327 | Progress in Medicinal Chemistry | journal | 1.293 Q1 | 38 | 5 | 17 | 534 | 61 | 1 | 3.27 | 106.80 | 0.00 | |
326 | Adverse Drug Reaction Bulletin | journal | 0.101 Q4 | 8 | 5 | 18 | 321 | 1 | 18 | 0.08 | 64.20 | 30.00 | |
325 | National Toxicology Program technical report series | journal | 0.211 | 22 | 0 | 19 | 0 | 25 | 19 | 1.55 | 0.00 | 0.00 | |
324 | Pharmaca | journal | 0.101 Q4 | 5 | 0 | 19 | 0 | 0 | 17 | 0.00 | 0.00 | 0.00 | |
323 | Farmaceutico Hospitales | journal | 0.112 Q4 | 3 | 0 | 21 | 0 | 1 | 13 | 0.00 | 0.00 | 0.00 | |
322 | Journal for ImmunoTherapy of Cancer | journal | 0.486 Q3 | 117 | 42 | 21 | 1801 | 47 | 20 | 2.24 | 42.88 | 34.11 | |
321 | Advances in Molecular Toxicology | book series | 0.334 Q3 | 18 | 7 | 22 | 1014 | 32 | 0 | 1.00 | 144.86 | 0.00 | |
320 | Autonomic and Autacoid Pharmacology | journal | 0.295 Q3 | 24 | 2 | 22 | 56 | 14 | 22 | 0.57 | 28.00 | 45.45 | |
319 | BMC Pharmacology | journal | 0.968 Q2 | 48 | 0 | 22 | 0 | 59 | 22 | 4.00 | 0.00 | 0.00 | |
318 | Proceedings of the Western Pharmacology Society | journal | 0.320 Q3 | 25 | 0 | 23 | 0 | 39 | 23 | 0.00 | 0.00 | 0.00 | |
317 | Open Medicinal Chemistry Journal | journal | 0.743 Q2 | 23 | 4 | 24 | 233 | 78 | 23 | 1.45 | 58.25 | 38.46 | |
316 | Core Evidence (discontinued) | journal | 0.983 Q2 | 29 | 13 | 26 | 713 | 105 | 26 | 4.21 | 54.85 | 43.75 | |
315 | Journal of Applied Research | journal | 0.131 Q4 | 23 | 4 | 26 | 102 | 11 | 26 | 0.47 | 25.50 | 41.18 | |
314 | PharmaNutrition | journal | 0.525 Q3 | 30 | 21 | 26 | 829 | 54 | 24 | 2.08 | 39.48 | 40.96 | |
313 | International Journal of Health Research | journal | 0.101 Q4 | 11 | 0 | 27 | 0 | 1 | 27 | 0.00 | 0.00 | 0.00 | |
312 | Pharmakeftiki | journal | 0.118 Q4 | 6 | 10 | 29 | 627 | 5 | 24 | 0.17 | 62.70 | 44.12 | |
311 | Oral Therapeutics and Pharmacology | journal | 0.102 Q4 | 6 | 6 | 31 | 128 | 2 | 31 | 0.00 | 21.33 | 18.52 | |
310 | Clinical Research and Regulatory Affairs | journal | 0.186 Q4 | 18 | 5 | 35 | 207 | 7 | 30 | 0.11 | 41.40 | 35.71 | |
309 | Iranian Journal of Pharmacology and Therapeutics | journal | 0.160 Q4 | 24 | 8 | 35 | 198 | 13 | 35 | 0.32 | 24.75 | 45.45 | |
308 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.172 Q4 | 29 | 10 | 36 | 877 | 28 | 0 | 0.72 | 87.70 | 0.00 | |
307 | Psychopharm Review | trade journal | 0.111 Q4 | 5 | 2 | 36 | 103 | 7 | 36 | 0.17 | 51.50 | 20.00 | |
306 | BMC Clinical Pharmacology | journal | 0.883 Q2 | 43 | 0 | 37 | 0 | 113 | 37 | 3.29 | 0.00 | 0.00 | |
305 | Interaction Design and Architecture(s) | journal | 0.165 Q4 | 19 | 37 | 37 | 1001 | 20 | 37 | 0.55 | 27.05 | 39.17 | |
304 | Journal of Pharmaceutical Negative Results (discontinued) | journal | 0.148 Q4 | 10 | 13 | 37 | 249 | 8 | 34 | 0.42 | 19.15 | 48.00 | |
303 | Bulletin of Pharmaceutical Sciences. Assiut | journal | 0.154 Q4 | 10 | 9 | 38 | 344 | 11 | 38 | 0.17 | 38.22 | 46.15 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®